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ﺍﻟﻤﻠﺨﺺ
ﺃﻫﺪﺍﻑﺍﻟﺒﺤﺚ:ﻟﺘﺤﺪﻳﺪﻣﺪﻯﺍﻧﺘﺸﺎﺭﺣﺴﺎﺳﻴﺔﺍﻟﻘﻤﺢﺑﻴﻦﺍﻷﻃﻔﺎﻝﻗﺼﺎﺭﺍﻟﻘﺎﻣﺔ.ﺇﻥﺣﺴﺎﺳﻴﺔﺍﻟﻘﻤﺢﻣﺮﺽﻭﺭﺍﺛﻲﻧﺎﺗﺞﻋﻦﺣﺴﺎﺳﻴﺔﺍﻟﻘﻤﺢ"ﺍﻟﻘﻠﻮﺗﻴﻦ"ﻳﺆﺩﻱﺇﻟﻰﺧﻠﻞﻓﻲﺍﻣﺘﺼﺎﺹﺍﻟﻐﺬﺍﺀ.
ﻭﻧﺴﺒﺔﻭﻗﻮﻋﻪﻋﺎﻟﻤﻴًﺎﻓﻲﺇﺭﺗﻔﺎﻉ.ﺃﺟﺮﻳﺖﺩﺭﺍﺳﺔﺍﺳﺘﻌﺎﺩﻳﺔﻣﻌﺘﻤﺪﺓﻋﻠﻰﺍﻟﻤﺴﺘﺸﻔﻰﻓﻲﻋﻴﺎﺩﺓﺍﻟﻐﺪﺩﺍﻟﺼﻤﺎﺀﻟﻸﻃﻔﺎﻝﻓﻲﻣﺴﺘﺸﻔﻰﺍﻟﻤﻠﻚﺧﺎﻟﺪﺍﻟﺠﺎﻣﻌﻲﻓﻲﺍﻟﺮﻳﺎﺽ.
ﻃﺮﻳﻘﺔﺍﻟﺒﺤﺚ:ﺗﻤﺖﻣﺮﺍﺟﻌﺔﻣﻠﻔﺎﺕﺍﻷﻃﻔﺎﻝﻗﺼﺎﺭﺍﻟﻘﺎﻣﺔﻓﻲﺍﻟﻔﺘﺮﺓﻣﺎﺑﻴﻦﻳﻨﺎﻳﺮ1990ﻡﻭﺩﻳﺴﻤﺒﺮ2009ﻡّﺍﺧﺬﻳﻦﺑﺎﻻﻋﺘﺒﺎﺭﺍﻟﺘﺎﺭﻳﺦﺍﻟﻤﺮﺿﻲﻭﺍﻟﻔﺤﺺﺍﻟﺴﺮﻳﺮﻱﻭﺧﺎﺻﻴﺔﺍﻟﻨﻤﻮ،
ﻭﺍﻟﻔﺤﺺﺍﻟﺸﻌﺎﻋﻲ)ﻋﻤﺮﺍﻟﻌﻈﻢ(ﺑﺎﻹﺿﺎﻓﺔﺇﻟﻰﺗﺤﻠﻴﻞﺍﻟﺪﻡﺍﻟﺮﻭﺗﻴﻨﻲﻭﺗﺤﻠﻴﻞﻭﻇﺎﺋﻒﺍﻟﻐﺪﺓﺍﻟﺪﺭﻗﻴﺔ.ﻛﻤﺎﺗﻢﻋﻤﻞﻓﺤﻮﺻﺎﺕﺍﻟﻜﺮﻭﻣﻮﺳﻮﻣﺎﺕﻋﻨﺪﺍﻟﻠﺰﻭﻡﻭﺍﺳﺘﻘﺼﺎﺀﺣﺴﺎﺳﻴﺔﺍﻟﻘﻤﺢﻣﻊﺃﺧﺬﻋﻴﻨﺔ
ﻣﻦﺍﻷﻣﻌﺎﺀﻋﻨﺪﺍﻟﻠﺰﻭﻡ.ﻛﺬﻟﻚﺗﻤﺖﺩﺭﺍﺳﺔﻫﺮﻣﻮﻧﺎﺕﺍﻟﻨﻤﻮﻣﻊﺍﻟﺘﺤﻔﻴﺰﻋﻨﺪﺍﻟﺤﺎﺟﺔﺑﺎﻹﺿﺎﻓﺔﺇﻟﻰﻓﺤﺺﺑﺎﻷﺷﻌﺔﺍﻟﻤﻐﻨﺎﻃﻴﺴﻴﺔﻟﻠﺤﺎﻻﺕﺍﻹﻳﺠﺎﺑﻴﺔ.
ﺍﻟﻨﺘﺎﺋﺞ:ﺗﻢﺗﻘﻴﻴﻢ110ﻣﻦﺍﻟﻤﺮﺿﻰﻗﺼﺎﺭﺍﻟﻘﺎﻣﺔﻣﻤﻦﺗﺘﺮﺍﻭﺡﺃﻋﻤﺎﺭﻫﻢﻣﺎﺑﻴﻦﺳﻨﺘﻴﻦﻭﻧﺼﻒﻭ14ﻋﺎﻣًﺎﻭﺫﻟﻚﻓﻲﺍﻟﻔﺘﺮﺓﺍﻟﻤﺤﺪﺩﺓﻟﻠﺒﺤﺚﻭﻛﺎﻧﺖﻧﺴﺒﺔﺍﻟﺬﻛﻮﺭﻟﻺﻧﺎﺙﻫﻲ1.3:1.ﻭﻛﺎﻧﺖ
ﺍﻟﻮﺭﺍﺛﺔﻫﻲﺍﻟﺴﺒﺐﺍﻟﺸﺎﺋﻊﻋﻨﺪ51.8%ﺑﻴﻨﻤﺎﻛﺎﻧﺖﺍﻷﺳﺒﺎﺏﻣﺨﺘﻠﻔﺔﻟﺪﻯ48.2%.ﻭﻛﺎﻥﻣﻦﺿﻤﻨﻬﻢ5ﻣﺮﺿﻰ)10%(ﻣﻤﻦﻟﺪﻳﻬﻢﺣﺴﺎﺳﻴﺔﺍﻟﻘﻤﺢ.ﻣﻤﺎﻳﻌﻨﻲ4.5%ﻣﻦﺟﻤﻴﻊﺣﺎﻻﺕ
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Abstract
Objective: To identify the prevalence of celiac disease (CD) among children with short stature. Celiac disease (CD) is genetically
determined gluten-sensitive enteropathy resulting in nutrient malabsorption, with an increasing incidence world-wide. A retrospec-
tive, hospital based study is conducted at a pediatric endocrine clinic, King Khalid University Hospital, Riyadh.
Methods: During the period between January 1990 and December 2009, the medical records of patients evaluated for short stature
were reviewed. After a proper detailed history and physical examination, growth analysis, followed by radiological (bone age), and
laboratory screening (CBC, and thyroid function) were performed. Celiac serological screening and chromosomal analysis were
performed when appropriate, followed by small intestinal biopsy if indicated. Growth hormone stimulation test was performed in
suspected patients, followed by magnetic resonance imaging (MRI) in positive cases.* Corresponding address: Department of Pediatrics, College of Medicine and King Khalid University Hospital, King Saud University, P.O.
Box 2925, Riyadh 11461, Kingdom of Saudi Arabia. Tel.: +966 01 467 0807; fax: +966 01 467 9463.
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Peer review under responsibility of Taibah University.
Production and hosting by Elsevier
1658-3612  2013 Taibah University. Production and hosting by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.jtumed.2013.03.003
Results: Hundred and ten patients were evaluated for short stature over the period under review. Their age ranged from 2.6 to
14 years. The male to female ratio was 1.3:1. The commonest cause was genetic and found in approximately 51.8%, while in the other
48.2%, variable endocrine and non-endocrine causes were noted. Of the non-genetic short stature, 5 (10%) patients were found to
have celiac disease, i.e. 4.5% of short children.
Conclusion: The prevalence of celiac disease is not rare in this study, therefore, celiac disease must be considered as an important
cause of short stature. As, it could be a silent disease, it is recommended that a serological screening be done first to all patients before
performing dynamic growth hormone testing in the evaluation of short stature.
Keywords: Anti-endomysial; Anti-tissue transglutaminase; Celiac disease; Children; Saudi; Short stature
 2013 Taibah University. Production and hosting by Elsevier Ltd. All rights reserved.
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Celiac disease (CD) is a genetically determined disease, with
permanent intolerance to ingested gluten that results in immu-
nologically mediated inflammatory damage to the small intes-
tinal mucosa. The prevalence of the disease in the general
population is approximately 0.8%,1 however, among children
with short stature, the highest reported prevalence has been
observed among Western Europeans and in countries to which
Europeans emigrated, notably, North America and Australia.2
In Brazil, the prevalence is reported to be 4.7%.3 However, it is
rare among people of purely African–Caribbean, Chinese, or
Japanese background.2
In Arab countries CD is not that uncommon,4 and limited
studies on the prevalence of CD in children, especially those
with short stature, showed a high prevalence of approximately
10%.5–7
Clinically infants with CD present with impaired growth,
diarrhea, and abdominal distension. Usually atypical presenta-
tion is seen, who often, have no overt features of malabsorp-
tion. Extra intestinal manifestations such as short stature,
delayed puberty, rickets, dental enamel defect, and arthralgia
may occur as monosymptomatic manifestations.8,9 The diag-
nosis of CD was based on clinical symptoms, positive serology
sub as serum IgA-class, antireticulum, antigliadin and antiend-
omysial antibodies and a small bowel biopsy.10–12 Histological
evidence of CD was usually reported according to the Oberh-
uber classification.13
The pathogenesis of CD associated short stature is still un-
clear. Besides the involvement of the growth hormone/insulin-
like growth factor-1 axis a role for ghrelin was recently
proposed.14,15
The purpose of the present study is to determine the prev-
alence of CD among a group of short children, attending a
pediatric endocrine clinic of King Khalid University Hospital
(KKUH), King Saud University, Riyadh, Kingdom of Saudi
Arabia, and highlights the importance of screening such chil-
dren for celiac disease by anti-endomysial and anti-tissue
transglutaminase antibodies before doing the time consuming
dynamic growth hormone testing.
Materials and Methods
During the period between January 1990 and December
2009, children with short stature referred to a pediatric
endocrine clinic, King Khalid University Hospital (KKUH),
King Saud University (KSU), Riyadh, Kingdom of Saudi
Arabia, were reviewed. After a proper detailed medical his-
tory, including nutritional history, parents’ and siblings’
height and age at puberty, birth weight, assessing the
growth velocity and, complete physical examination, fol-
lowed by radiological assessment including a bone age,16
and appropriate laboratory screening (complete blood
count, erythrocyte sedimentation rate, liver, renal and bone
profiles and thyroid function) were done. A harbender sta-
diometer was used for height measurement. Chromosomal
analysis was performed in the peripheral blood in females
with otherwise unexplained short stature to rule out Turn-
er’s syndrome. In those patients with sub-normal growth
velocity (growth velocity <4 cm/year) dynamic growth
hormone testing was performed following a standard proce-
dure (one physiological and two biochemical testing).17–20
Although, a random serum growth hormone value of more
than 10 mg/dl generally exclude growth hormone deficiency
(GHD), a random low serum growth hormone concentra-
tion does not confirm the diagnosis of GHD.17–20 In
patients with proved growth hormone deficiency, magnetic
resonance of the pituitary (MRI) was performed. Celiac
screening, for Celiac Disease was undertaken, using
the endomysial antibodies in all short children with unex-
plained short stature, and confirmed by small biopsy if
indicated.10–13
Results
During the period under review, January 1990 to Decem-
ber 2009, one hundred and ten patients with short stature
were evaluated at a pediatric endocrine clinic, King Khalid
University Hospital (KKUH), King Saud University
(KSU), Riyadh, Kingdom of Saudi Arabia. Their age ran-
ged between 2.6 and 14 years. The male to female ratio
was 1.3:1. A wide spectrum of etiological causes of short
stature was seen. Table 1 showed that the commonest
form of short stature is genetic accounting for 51.8%.
Various causes were noted (Table 2). Five patients in the
non-genetic group were having positive serology for celiac
disease, which were later confirmed by small bowel biopsy.
Two of them were having other autoimmune disorders, i.e.
one child was having diabetes and hypothyroidism while
the other one was having type 1-polyglandular
autoimmunity.
Table 2: The non-genetic etiology among 110 children with short
stature (53 children).
Aetiology No. of patients Percentage
(%)
Idiopathic growth hormone deficiency 7 13.3
Primary hypothyroidism 6 11.5
Rickets/skeletal dysplasia 6 11.5
Celiac disease 5 9.5
Small for gestational age 5 9.5
Congenital adrenal hyperplasia 4 7.6
Dysmorphic child 4 7.6
Turner’s syndrome 3 5.7
Laron dwarfism 2 3.8
Empty sella syndrome 2 3.8
Craniopharyngioma 2 3.8
Septo-optic-hypoplasia 2 3.8
Partial panhypopituitarism 2 3.8
Subarachnoid cyst 1 1.9
Histocytosis-X- 1 1.9
Pseudohypoparathyroidism 1 1.9
Table 1: Etiology of short stature in 110 children.
Cause No. of patients Percentage (%)
Genetic short stature 57 51.8
Familial short stature 53
Constitutional growth delay 4
Non-genetic short stature 53 48.2
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showed a prevalence of approximately 10%.5–7 All children had
no gastrointestinal symptoms. Screening for Celiac Disease is
initiated with serological evaluation using IgA anti-tissue trans-
glutaminase and IgA endomysial antibodies, with documenta-
tion of normal IgA levels. These tests have higher sensitivity
and specificity than previously used anti-gliadin antibody
tests.12 Celiac Disease can lead to short stature by causing auto-
immune hypothyroidism, resistance to growth hormone, and
malabsorption of protein, calcium and vitaminD.Additionally,
Celiac Disease can lead to hypogonadism which inhibits the
pubertal growth spurt.15 It is recommended by the American
Diabetes Association Clinical Practice that antibody screening
should be done in patients with type 1 diabetes.25 Also, Down
Syndrome has increased susceptibility to autoimmune dis-
eases.26 Patients with positive antibodies should be referred to
a gastroenterologist for confirmation by small intestinal biopsy
and to a dietitian for instruction on a gluten-free diet.
In conclusion, the prevalence of Celiac Disease is not rare in
our community, in particular among children with short stat-
ure. Celiac Disease must be considered as an important cause
and, therefore, should be screened for utilizing the available,
simple, very sensitive and specific serological test which is
much cheaper and less invasive than doing the dynamic growth
hormone testing to start with.
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